These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28662136)

  • 41. Enhancing hepatic fibrosis in spontaneously hypertensive rats fed a choline-deficient diet: a follow-up report on long-term effects of oxidative stress in non-alcoholic fatty liver disease.
    Yamamoto H; Kanno K; Ikuta T; Arihiro K; Sugiyama A; Kishikawa N; Tazuma S
    J Hepatobiliary Pancreat Sci; 2016 May; 23(5):260-9. PubMed ID: 26880573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and -10 in spontaneously hypertensive rats with steatohepatitis.
    Kozono M; Uto H; Ibusuki R; Arima S; Oda K; Taguchi H; Sasaki F; Nasu Y; Hashimoto S; Setoyama H; Kanmura S; Numata M; Tsubouchi H; Ido A
    Mol Med Rep; 2016 Dec; 14(6):5385-5394. PubMed ID: 27779710
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered Gut Microbiota Composition and Immune Response in Experimental Steatohepatitis Mouse Models.
    Ishioka M; Miura K; Minami S; Shimura Y; Ohnishi H
    Dig Dis Sci; 2017 Feb; 62(2):396-406. PubMed ID: 27913996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-21 is associated with fibrosis in a rat model of nonalcoholic steatohepatitis and serves as a plasma biomarker for fibrotic liver disease.
    Takeuchi-Yorimoto A; Yamaura Y; Kanki M; Ide T; Nakata A; Noto T; Matsumoto M
    Toxicol Lett; 2016 Sep; 258():159-167. PubMed ID: 27320964
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats.
    Nakano T; Cheng YF; Lai CY; Hsu LW; Chang YC; Deng JY; Huang YZ; Honda H; Chen KD; Wang CC; Chiu KW; Jawan B; Eng HL; Goto S; Chen CL
    J Hepatol; 2011 Aug; 55(2):415-25. PubMed ID: 21184788
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thrombospondin-I is a critical modulator in non-alcoholic steatohepatitis (NASH).
    Min-DeBartolo J; Schlerman F; Akare S; Wang J; McMahon J; Zhan Y; Syed J; He W; Zhang B; Martinez RV
    PLoS One; 2019; 14(12):e0226854. PubMed ID: 31891606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of hepatic neuropeptide Y-Y1 receptors in a methionine-choline-deficient model of non-alcoholic steatohepatitis.
    Sun WW; ShangGuan T; Zhu P; Li HK; Jiang M; Yang P; Li LY; Zhang ZH
    Life Sci; 2020 Mar; 245():117356. PubMed ID: 31991181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor.
    Duan X; Meng Q; Wang C; Liu Z; Liu Q; Sun H; Sun P; Yang X; Huo X; Peng J; Liu K
    Phytomedicine; 2017 Feb; 25():83-92. PubMed ID: 28190475
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fucoxanthin inhibits hepatic oxidative stress, inflammation, and fibrosis in diet-induced nonalcoholic steatohepatitis model mice.
    Takatani N; Kono Y; Beppu F; Okamatsu-Ogura Y; Yamano Y; Miyashita K; Hosokawa M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):305-310. PubMed ID: 32475638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet.
    Kajikawa S; Imada K; Takeuchi T; Shimizu Y; Kawashima A; Harada T; Mizuguchi K
    Dig Dis Sci; 2011 Apr; 56(4):1065-74. PubMed ID: 20848203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes.
    Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.
    Miyaki T; Nojiri S; Shinkai N; Kusakabe A; Matsuura K; Iio E; Takahashi S; Yan G; Ikeda K; Joh T
    Hepatol Res; 2011 Apr; 41(4):375-85. PubMed ID: 21276150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention by methionine of enhancement of hepatocarcinogenesis by coadministration of a choline-deficient L-amino acid-defined diet and ethionine in rats.
    Tsujiuchi T; Kobayashi E; Nakae D; Mizumoto Y; Andoh N; Kitada H; Ohashi K; Fukuda T; Kido A; Tsutsumi M
    Jpn J Cancer Res; 1995 Dec; 86(12):1136-42. PubMed ID: 8636001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of Trifolium pratense extract on methionine-choline-deficient diet-induced steatohepatitis in C57BL/6 mice.
    Chen T; Zhong FJ; Hong YM; Su WJ; Zhuang LL; Qiu LX
    Chin J Nat Med; 2014 Mar; 12(3):194-8. PubMed ID: 24702805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
    Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
    Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
    J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
    Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
    Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conophylline inhibits non-alcoholic steatohepatitis in mice.
    Nakade Y; Sakamoto K; Yamauchi T; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Sumida Y; Ito K; Nakao H; Fukuzawa Y; Umezawa K; Yoneda M
    PLoS One; 2017; 12(6):e0178436. PubMed ID: 28594915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Andrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis.
    Cabrera D; Wree A; Povero D; Solís N; Hernandez A; Pizarro M; Moshage H; Torres J; Feldstein AE; Cabello-Verrugio C; Brandan E; Barrera F; Arab JP; Arrese M
    Sci Rep; 2017 Jun; 7(1):3491. PubMed ID: 28615649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.